Stay updated with breaking news from Nasdaq Agle. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a report released on Monday morning. The brokerage issued a hold rating on the biotechnology company’s stock. AGLE has been the topic of a number of other research reports. Jonestrading restated a hold rating on shares of Aeglea BioTherapeutics in a research […]
StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a research report released on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Other research analysts have also recently issued research reports about the company. HC Wainwright reiterated a neutral rating and set a $1.00 price objective […]
Shares of Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE – Get Rating) have been given an average rating of “Hold” by the seven brokerages that are presently covering the firm, Marketbeat Ratings reports. Six analysts have rated the stock with a hold rating. The average 1 year price target among analysts that have issued a report on the […]
StockNews.com assumed coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a research report report published on Saturday morning. The firm issued a hold rating on the biotechnology company’s stock. A number of other equities analysts have also issued reports on AGLE. Lifesci Capital lowered Aeglea BioTherapeutics from an outperform rating to a […]
StockNews.com started coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE – Get Rating) in a report issued on Saturday. The firm issued a hold rating on the biotechnology company’s stock. Other research analysts have also issued reports about the company. Lifesci Capital lowered Aeglea BioTherapeutics from an outperform rating to a market perform rating in a […]